サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1763985

コンパニオンアニマル診断市場- 世界の産業規模、シェア、動向、機会、予測、動物タイプ別、技術別、地域別セグメント、競合、2020年～2030年

Companion Animal Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Animal Type, By Technology, By Region and Competition, 2020-2030F

出版日
ページ情報
英文 185 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.05円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

コンパニオンアニマル診断市場- 世界の産業規模、シェア、動向、機会、予測、動物タイプ別、技術別、地域別セグメント、競合、2020年～2030年
出版日: 2025年06月30日
発行: TechSci Research
ページ情報: 英文 185 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

コンパニオンアニマル診断の世界市場は、2024年には28億米ドルと評価され、2030年には42億米ドルに達し、CAGR 7.21％で成長すると予測されています。

ペットのヒューマニゼーションが進むにつれ、予防ヘルスケアと病気の早期発見が重視されるようになり、高度な診断ツールやサービスの需要が急増しています。家庭は、犬や猫、その他の家畜などのペットの健康により多くの投資を行うようになり、ペットを不可欠な家族の一員として扱うようになっています。このような消費者の考え方の変化は、獣医療、特に診断のあり方を変えつつあります。分子診断、ポイント・オブ・ケア・キット、改良された画像診断システムなどの技術的進歩により、獣医師による幅広い健康問題の検出能力が向上しています。しかし、高度な診断ツールのコストが高いことや、訓練を受けた獣医師が限られた地域でしか利用できないことなどが、市場の拡大を抑制しています。このような障害にもかかわらず、革新的で正確かつ利用しやすい診断ソリューションに対する需要は伸び続けており、見通しは明るいです。

市場概要
予測期間 2026-2030
市場規模：2024年 28億米ドル
市場規模：2030年 42億米ドル
CAGR：2025年～2030年 7.21%
急成長セグメント 犬
最大市場 北米

市場促進要因

ヘルスケア産業の成長

主な市場課題

高度診断の高コスト

主要市場動向

特殊な診断モダリティの成長

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 COVID-19が世界のコンパニオンアニマル診断市場に与える影響

第5章 世界のコンパニオンアニマル診断市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • 動物タイプ別（犬、猫、馬、その他）
    • 技術別（臨床生化学、臨床化学分析、血糖モニタリング、血液ガスおよび電解質分析、免疫診断、血液学、尿検査、その他）
    • 地域別
    • 企業別（2024）
  • 市場マップ

第6章 北米のコンパニオンアニマル診断市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 北米：国別分析
    • 米国
    • メキシコ
    • カナダ

第7章 欧州のコンパニオンアニマル診断市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 欧州：国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第8章 アジア太平洋地域のコンパニオンアニマル診断市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • アジア太平洋地域：国別分析
    • 中国
    • インド
    • 韓国
    • 日本
    • オーストラリア

第9章 南米のコンパニオンアニマル診断市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカのコンパニオンアニマル診断市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 中東・アフリカ：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 合併と買収
  • 製品上市
  • 最近の動向

第13章 混乱：紛争、パンデミック、貿易障壁

第14章 世界のコンパニオンアニマル診断市場：SWOT分析

第15章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第16章 競合情勢

  • IDEXX Laboratories, Inc.
  • Zoetis Inc.
  • Virbac
  • Heska Corporation
  • Neogen Corporation
  • Bio-Rad Laboratories, Inc.
  • INDICAL Bioscience GmbH
  • Agrolabo SpA
  • ID.vet
  • bioMerieux S.A.

第17章 戦略的提言

第18章 調査会社について・免責事項

目次
Product Code: 5059

The Global Companion Animal Diagnostics Market was valued at USD 2.80 Billion in 2024 and is projected to reach USD 4.20 Billion by 2030, growing at a CAGR of 7.21%. With the rising humanization of pets, there is increasing emphasis on preventive healthcare and early disease detection, leading to a surge in demand for advanced diagnostic tools and services. Households are investing more in the well-being of pets such as dogs, cats, and other domesticated animals, treating them as integral family members. This evolving consumer mindset is reshaping veterinary care, particularly diagnostics. Technological advancements, including molecular diagnostics, point-of-care kits, and improved imaging systems, have enhanced veterinarians' ability to detect a wide range of health issues. However, market expansion is tempered by the high cost of sophisticated diagnostic tools and limited availability of trained veterinary personnel in some areas. Despite these barriers, the outlook remains positive as demand continues to grow for innovative, accurate, and accessible diagnostic solutions.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 2.80 Billion
Market Size 2030USD 4.20 Billion
CAGR 2025-20307.21%
Fastest Growing SegmentDogs
Largest MarketNorth America

Key Market Drivers

Growth in Healthcare Industry

The consistent growth of the global healthcare industry has significantly influenced the advancement of the companion animal diagnostics market. Generating over USD 4 trillion annually, the industry includes key segments such as pharmaceuticals and biotechnology-together worth nearly USD 850 billion-and medical technology and diagnostics, contributing more than USD 400 billion. This growth has led to a parallel investment trend in veterinary healthcare technologies. The increasing humanization of pets is one of the main contributors to this shift, with pet owners-particularly in developed regions-prioritizing preventive diagnostics and early detection of illnesses. This willingness to invest in comprehensive pet care is accelerating the adoption of advanced diagnostic tools across veterinary practices.

Key Market Challenges

High Cost of Advanced Diagnostics

The financial burden associated with advanced diagnostics is a major constraint for broader adoption in the global companion animal diagnostics market. Modern diagnostic systems, including molecular and genetic testing as well as digital imaging, require significant investments in infrastructure, equipment, and trained personnel. These costs are often too high for small veterinary practices or clinics in emerging economies. Unlike human healthcare, which may benefit from public funding or insurance schemes, most veterinary services are paid out-of-pocket by pet owners. Even with increasing use of pet insurance, reimbursement for high-end diagnostics is often limited, restricting access to these technologies and creating disparities in the standard of care available to pet owners.

Key Market Trends

Growth of Specialized Diagnostic Modalities

An emerging trend in the companion animal diagnostics market is the shift toward specialized and precision-focused diagnostic modalities. Veterinary medicine is evolving rapidly, and there is a growing need for diagnostic tools that provide targeted, early, and accurate disease detection. Technologies such as molecular diagnostics, immunodiagnostics, and advanced imaging are being adopted more widely to detect conditions before symptoms appear. These tools are particularly valuable for identifying genetic disorders, monitoring chronic disease progression, and assessing treatment response. Companies such as Pawsperity Biotechnologies are contributing to this trend by developing cutting-edge molecular diagnostics tailored for veterinary use, signaling a broader industry movement toward precision veterinary care.

Key Market Players

  • IDEXX Laboratories, Inc.
  • Zoetis Inc.
  • Virbac
  • Heska Corporation
  • Neogen Corporation
  • Bio-Rad Laboratories, Inc.
  • INDICAL Bioscience GmbH
  • Agrolabo SpA
  • ID.vet
  • bioMerieux S.A.

Report Scope

In this report, the Global Companion Animal Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Companion Animal Diagnostics Market, By Animal Type:

  • Dogs
  • Cats
  • Horses
  • Others

Companion Animal Diagnostics Market, By Technology:

  • Clinical Biochemistry
  • Clinical Chemistry Analysis
  • Glucose Monitoring
  • Blood Gas & Electrolyte Analysis
  • Immunodiagnostics
  • Hematology
  • Urinalysis
  • Others

Companion Animal Diagnostics Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Companion Animal Diagnostics Market.

Available Customizations:

Global Companion Animal Diagnostics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Companion Animal Diagnostics Market

5. Global Companion Animal Diagnostics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Animal Type (Dogs, Cats, Horses, Others)
    • 5.2.2. By Technology (Clinical Biochemistry, Clinical Chemistry Analysis, Glucose Monitoring, Blood Gas & Electrolyte Analysis, Immunodiagnostics, Hematology, Urinalysis, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Companion Animal Diagnostics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Animal Type
    • 6.2.2. By Technology
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Companion Animal Diagnostics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Animal Type
        • 6.3.1.2.2. By Technology
    • 6.3.2. Mexico Companion Animal Diagnostics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Animal Type
        • 6.3.2.2.2. By Technology
    • 6.3.3. Canada Companion Animal Diagnostics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Animal Type
        • 6.3.3.2.2. By Technology

7. Europe Companion Animal Diagnostics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Animal Type
    • 7.2.2. By Technology
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Companion Animal Diagnostics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Animal Type
        • 7.3.1.2.2. By Technology
    • 7.3.2. Germany Companion Animal Diagnostics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Animal Type
        • 7.3.2.2.2. By Technology
    • 7.3.3. United Kingdom Companion Animal Diagnostics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Animal Type
        • 7.3.3.2.2. By Technology
    • 7.3.4. Italy Companion Animal Diagnostics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Animal Type
        • 7.3.4.2.2. By Technology
    • 7.3.5. Spain Companion Animal Diagnostics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Animal Type
        • 7.3.5.2.2. By Technology

8. Asia Pacific Companion Animal Diagnostics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Animal Type
    • 8.2.2. By Technology
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Companion Animal Diagnostics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Animal Type
        • 8.3.1.2.2. By Technology
    • 8.3.2. India Companion Animal Diagnostics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Animal Type
        • 8.3.2.2.2. By Technology
    • 8.3.3. South Korea Companion Animal Diagnostics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Animal Type
        • 8.3.3.2.2. By Technology
    • 8.3.4. Japan Companion Animal Diagnostics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Animal Type
        • 8.3.4.2.2. By Technology
    • 8.3.5. Australia Companion Animal Diagnostics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Animal Type
        • 8.3.5.2.2. By Technology

9. South America Companion Animal Diagnostics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Animal Type
    • 9.2.2. By Technology
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Companion Animal Diagnostics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Animal Type
        • 9.3.1.2.2. By Technology
    • 9.3.2. Argentina Companion Animal Diagnostics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Animal Type
        • 9.3.2.2.2. By Technology
    • 9.3.3. Colombia Companion Animal Diagnostics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Animal Type
        • 9.3.3.2.2. By Technology

10. Middle East and Africa Companion Animal Diagnostics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Animal Type
    • 10.2.2. By Technology
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Companion Animal Diagnostics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Animal Type
        • 10.3.1.2.2. By Technology
    • 10.3.2. Saudi Arabia Companion Animal Diagnostics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Animal Type
        • 10.3.2.2.2. By Technology
    • 10.3.3. UAE Companion Animal Diagnostics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Animal Type
        • 10.3.3.2.2. By Technology

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Disruptions : Conflicts, Pandemics and Trade Barriers

14. Global Companion Animal Diagnostics Market: SWOT Analysis

15. Porters Five Forces Analysis

  • 15.1. Competition in the Industry
  • 15.2. Potential of New Entrants
  • 15.3. Power of Suppliers
  • 15.4. Power of Customers
  • 15.5. Threat of Substitute Products

16. Competitive Landscape

  • 16.1. IDEXX Laboratories, Inc.
    • 16.1.1. Business Overview
    • 16.1.2. Company Snapshot
    • 16.1.3. Products & Services
    • 16.1.4. Financials (As Reported)
    • 16.1.5. Recent Developments
    • 16.1.6. Key Personnel Details
    • 16.1.7. SWOT Analysis
  • 16.2. Zoetis Inc.
  • 16.3. Virbac
  • 16.4. Heska Corporation
  • 16.5. Neogen Corporation
  • 16.6. Bio-Rad Laboratories, Inc.
  • 16.7. INDICAL Bioscience GmbH
  • 16.8. Agrolabo SpA
  • 16.9. ID.vet
  • 16.10. bioMerieux S.A.

17. Strategic Recommendations

18. About Us & Disclaimer